Bharat Biotech, Bilthoven Biologicals Collaborate For Oral Polio Vaccines

Mumbai: Vaccine manufacturer Bharat Biotech and Bilthoven Biologicals, a subsidiary of Serum Institute of India, on Tuesday announced a partnership to produce and supply oral polio vaccines (OPVs) worldwide.

In this agreement, Bharat Biotech will source drug substances from Bilthoven Biologicals for manufacturing oral polio vaccines, which will be distributed in India and globally. The collaboration will also involve obtaining the necessary regulatory approvals to commercially manufacture OPVs in India using the drug substances produced in the Netherlands.

Speaking on the partnership, Adar Poonawalla, chief executive officer of Serum Institute of India, said, “We are delighted to join forces with Bharat Biotech. Our vision is to eradicate polio worldwide, taking a crucial step towards reducing the impact of this deadly disease on vulnerable populations.”

Commenting on the same, Krishna Ella, executive chairman of Bharat Biotech said, “Oral polio vaccines have been an integral part of the Government of India’s Universal Immunisation Programme. This collaboration between Bharat Biotech and Bilthoven Biologicals exemplifies cooperation between vaccine companies, ensuring a secure supply of oral polio vaccines and fortifies the nation’s mission to eradicate polio.”

Bharat Biotech is a biotech company based in India and is a global supplier of vaccines and biotherapeutics. The company has manufactured and supplied over nine billion vaccine doses globally.

Established in 1966, Serum Institute of India is a global leader in vaccine production. Bilthoven Biologicals was established after the privatisation of NVI (Netherlands). Bilthoven Biologicals was acquired by the Cyrus Poonawalla Group in 2012. This acquisition provided Serum Institute with access to technology and expertise for making injectable polio vaccines.

Related Posts

  • Pharma
  • April 24, 2024
  • 45 views
Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

Kathmandu: In a bid to ensure the quality of medicines being prescribed to patients, the Department of Drug Administration (DDA) has been preparing to carry out on-site tests of medicines. For…

  • Pharma
  • April 23, 2024
  • 31 views
‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

Ranchi : Patanjali’s case is going on in the Supreme Court for misleading people by showing misleading advertisements. But there are many other pharmaceutical companies in this category. In fact,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

Misleading Ads Case: Patanjali Issues Public Apology In A Daily Newspaper

Misleading Ads Case: Patanjali Issues Public Apology In A Daily Newspaper

AFMS Collaborates With IIT Delhi To Develop Medical Devices

AFMS Collaborates With IIT Delhi To Develop Medical Devices

Ayush Ministry Told To Act Against Firm Selling Medicine Named ‘Insulin’

Ayush Ministry Told To Act Against Firm Selling Medicine Named ‘Insulin’

2 Youths Arrested With 44770 Pregabalin Capsules

2 Youths Arrested With 44770 Pregabalin Capsules